More Than a Year Later, Americord Maintains Highest Quality Guarantee


New York – August 20, 2013 – Today, more than one year after Americord Registry announced the launch of its $80,000 quality guarantee, the company remains the only one in the cord blood banking industry to offer parents this level of financial protection. Its closest competitors, all of which charge parents-to-be significantly higher fees for cord blood banking, offer parents-to-be significantly lower quality guarantees – generally between $25,000 and $50,000.

“Expertise, service, and value are the three pillars that Americord is built upon,” said Americord CEO Martin Smithmyer. “We adhere to the highest scientific standards in the industry, we offer the most comprehensive service, and we give parents-to-be the greatest value in the cord blood industry.” Americord offers cord blood banking for approximately 50% less than its competitors, and Americord’s price includes the cost of a medical courier as well as 20 years of storage in their state-of-the-art CLIA Certified, AABB accredited laboratory.

Leading cord blood banks offer quality guarantees to provide financial protection to parents in the unlikely event that the stem cells they have banked are needed, but, upon medical use, fail to “engraft”. “Engrafting” is key to a successful stem cell transplant. Stem cell transplants are a medical therapy that can be used to treat a variety of diseases, including leukemia, lymphoma, and certain genetic diseases such as sickle cell anemia.

Under Americord’s quality guarantee, in the event that a client’s stem cells fail to engraft, Americord will pay up to $80,000 to defray the cost of the procurement of an alternative source of stem cells or to seek alternative treatment, if medically indicated.

In a blog post this week, Smithmyer said, “Americord’s industry-leading $80,000 quality guarantee is one of many steps we take to offer parents-to-be greater peace of mind and lower financial stress as they prepare for the birth of their child.”

Please note: Americord Registry's activities are limited to collection of umbilical cord tissue from autogeneic donors. Americord Registry's possession of a New York State license for such collection does not indicate approval or endorsement of possible future uses or future suitability of cells derived from umbilical cord tissue. Cord blood and tissue prices are subject to change. Copyright 2008-2013 Americord Registry LLC Cord Blood Bank. All rights reserved. Americord Registry is headquartered in New York, NY.